Blue Owl Capital’s real‑estate arm announced a definitive merger agreement to acquire Sila Realty Trust, Inc. (NYSE: SILA) in an all‑cash transaction valued at approximately $2.4 billion. The deal will pay Sila shareholders $30.38 per share, a 19.0 % premium to the company’s closing price on April 17 and a 25.6 % premium to the 30‑day volume‑weighted average price.
The transaction is expected to close in the second or third quarter of 2026, subject to customary regulatory approvals and shareholder consent. Upon completion, Sila will become a private company and be delisted from the NYSE.
Sila is a net‑lease REIT that focuses exclusively on healthcare properties. As of March 31 2026, it owned 137 income‑generating properties and three undeveloped land parcels across 65 markets. The portfolio is composed of triple‑net leases with high‑quality tenants such as hospitals, senior‑care facilities, and outpatient centers, providing durable cash flows and low vacancy risk.
Blue Owl’s acquisition aligns with its strategy to expand its net‑lease franchise beyond data‑center and artificial‑intelligence assets. The company’s real‑assets division accounts for roughly a quarter of its $307 billion in assets under management as of December 31 2025, and the addition of Sila’s healthcare portfolio strengthens its exposure to a defensive, essential sector.
Sila’s most recent quarterly results, released in March 2026, showed a $0.09 earnings per share, missing analyst consensus of $0.17 by 47 %. Revenue of $50.7 million beat expectations of $50.18 million, driven by a modest increase in same‑store cash net operating income and acquisitions that added new assets. The miss in earnings was largely attributable to a lease‑termination fee and a severance payment received from GenesisCare USA, Inc., which offset gains from operating income growth.
Management highlighted the strategic fit of the transaction. President and CEO Michael A. Seton said the deal would provide “significant and immediate realized benefit to our shareholders” and underscored the company’s focus on high‑quality, long‑term net‑lease assets. Blue Owl’s Co‑President and Global Head of Real Assets Marc Zahr noted that the acquisition would give the firm a “best‑in‑class healthcare net‑lease portfolio” and further diversify its exposure to a resilient sector.
The announcement was well received by investors, with analysts noting the premium and all‑cash nature as key attractions, underscoring the market’s preference for immediate value realization over continued independent operation.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.